Following People With Lymphoma Treated at Samsung Medical Center
Follows people with aggressive lymphoma, including Hodgkin and non-Hodgkin types, over time.
Key facts
- Who runs it
- Samsung Medical Center
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 1 Jun 2022
- Expected to end
- 30 Dec 2028
- Type of study
- Observational
- Treatments tested
- Immunochemotherapy
- Record updated
- 13 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Hodgkin or non-Hodgkin lymphoma who need chemotherapy meant to remove all of the disease.
- Age
- 20 years
- Sex
- All sexes can join.
- Disease stage
- Hodgkin or non-Hodgkin lymphoma, confirmed by pathology (tissue examination). The record describes aggressive lymphoma.
Main reasons for not taking part
- Myeloid malignancy
- Multiple myeloma
- No need for chemotherapy meant to remove all of the disease
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Pathologically diagnosed Hodgkin and non-Hodgkin lymphomas
- 20 years
- Patients requiring systemic chemotherapy with curative intent
- Written informed consent
Who cannot take part
- Patients do not require systemic chemotherapy with curative intent
- Myeloid malignancy
- Multiple myeloma
Where in South Korea
- Samsung Medical CenterSeoul, South KoreaContact: Seok Jin Kim, MD., PhD.Taking people
About the trial
What the trial wants to find out
This prospective study enrolls patients who are diagnosed with aggressive lymphoma including Hodgkin and non-Hodgkin lymphomas. Enrolled patients will be treated according to our institution' treatment policy in clinical practice. The disease status including response to therapy and survival status will be regularly updated during the study period. Patients' serum and cell-free DNA will be collected and analyzed.
Treatments tested
- Immunochemotherapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Study for Patients With Lymphoma at the Samsung Medical Center
- Plain-language title
- Following People With Lymphoma Treated at Samsung Medical CenterGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 13 October 2026